Diabetes Medication to Reduce Age-Related Eye Disorders Beyond Glucose Control-Reply
JAMA Ophthalmol
.
2023 Apr 1;141(4):405-406.
doi: 10.1001/jamaophthalmol.2022.6317.
Authors
Joëlle E Vergroesen
1
2
,
Caroline C W Klaver
1
2
3
4
5
,
Wishal D Ramdas
1
Affiliations
1
Department of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
2
Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
3
EyeNED Reading Center, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
4
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.
5
Institute of Molecular and Clinical Ophthalmology, University of Basel, Basel, Switzerland.
PMID:
36795385
DOI:
10.1001/jamaophthalmol.2022.6317
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose
Diabetes Mellitus, Type 2* / drug therapy
Eye Diseases* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Medication Adherence
Substances
Blood Glucose
Hypoglycemic Agents